Leading Infectious Disease Biomaterial Manufacturer

Copan FLOQSwab® and Liquid Control Products
- Clinical Diagnostics,
- Proficiency Programs,
- Training, Verification and Development
Antigens for Diagnostic Test Manufacturers
Viral Transport Medium – DxTM™

Microbix Hosts Ontario Minister Stephen Crawford

Microbix Biosystems announces its hosting of the Honourable Stephen Crawford, Ontario’s Minister of Public and Business Service Delivery and Procurement, for a site visit to tour the company’s advanced biotechnology development and manufacturing facilities and discuss how next generation diagnostics can improve health outcomes while reducing healthcare costs for Ontarians.

Microbix’s Corporate Presentation

Profitable growth from supporting next generation Diagnostics. Click below to download..

Microbix Reports Results for Q3 Fiscal 2025

Microbix Biosystems reports results for its third quarter and nine months of fiscal 2025 ended June 30, 2025 (“Q3” and “YTD”). Sales for Q3 were down for both Antigens and QAPs™, while YTD Antigens were up and QAPs were down YTD.

QAPS

Why choose Microbix Quality Assessment Products (QAPs)? Find out more.

infectious-diseas-antigens-3_55600834-e67d-4aa2-ad6b-59096ce3b3c8

INFECTIOUS DISEASE ANTIGENS

Microbix produces one of the world’s broadest range of infectious disease antigens.

PARTNERSHIP OPPORTUNITIES

Microbix has a partnership opportunity. Check it out here.

Our Commitment to Quality

Our quality process ensures our customers receive products that meet and exceed their needs and expectations. Our quality management system takes into consideration regulatory requirements that are applicable to the type of products we manufacture and the industries we serve.